Mango Supplement for PreDiabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
PreDiabetes+3 More
Mango - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study the effects of mango consumption on blood sugar levels, heart health, and body composition in overweight and obese people with prediabetes.

Eligible Conditions
  • PreDiabetes
  • Obesity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for PreDiabetes

Study Objectives

5 Primary · 14 Secondary · Reporting Duration: 3 years

3 years
Atherogenic risk ratio (TC/HDL-C, LDLC/HDL-C, HDL-C/LDL-C)
Effect of mango consumption on anthropometric measure WC/HC ratio
Effect of mango consumption on anthropometric measure of HC
Waist Circumference
Effect of mango consumption on body composition evaluated by fat mass
Effect of mango consumption on body composition evaluated by lean mass
Effect of mango consumption on body composition evaluated by phase angle (PA)
Effect of mango consumption on body composition evaluated by weight
Effect of mango consumption on glycemic control evaluated by HOMA-IR
Effect of mango consumption on glycemic control evaluated by HOMA-β
Effect of mango consumption on glycemic control evaluated by Insulin
Effect of mango consumption on glycemic control using HbA1c
Blood Glucose
Effect of mango consumption on indicators of cardiovascular health evaluated by Indirect bioassay of in vivo endothelial function with ET-1
Effect of mango consumption on indicators of cardiovascular health evaluated by Indirect bioassay of in vivo endothelial function with FMD
Effect of mango consumption on indicators of cardiovascular health evaluated by Indirect bioassay of in vivo endothelial function with PWV
Inflammation
Lipids
Effect of mango consumption on indicators of cardiovascular health evaluated by systolic and diastolic blood pressure

Trial Safety

Safety Progress

1 of 3

Other trials for PreDiabetes

Trial Design

2 Treatment Groups

Mango Supplement
1 of 2
Placebo Matched Supplement
1 of 2
Experimental Treatment
Non-Treatment Group

40 Total Participants · 2 Treatment Groups

Primary Treatment: Mango Supplement · Has Placebo Group · N/A

Mango Supplement
Other
Experimental Group · 1 Intervention: Mango · Intervention Types: Other
Placebo Matched Supplement
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 years

Who is running the clinical trial?

National Mango BoardOTHER
4 Previous Clinical Trials
192 Total Patients Enrolled
Florida State UniversityLead Sponsor
157 Previous Clinical Trials
27,344 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are free of any chronic diseases such as cancer.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 22nd, 2021

Last Reviewed: October 27th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.